NASDAQ:XLO

Xilio Therapeutics Stock Forecast

etoro logo Buy XLO
*Your capital is at risk
$8.65
+0.340 (+4.09%)
At Close: Jul 24, 2026
AI Analysis AI Analysis of XLO AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add XLO to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Stronger technical forecast for Xilio Therapeutics, Inc. stock price after Friday trading
(Updated on Jul 24, 2026)

Hold candidate since Jul 24, 2026

The Xilio Therapeutics, Inc. stock price gained 4.09% on the last trading day (Friday, 24th Jul 2026), rising from $8.31 to $8.65. During the last trading day the stock fluctuated 3.96% from a day low at $8.33 to a day high of $8.66. The price has fallen in 6 of the last 10 days and is down by -4.95% for this period. Volume fell on the last day by -34 thousand shares and in total, 17 thousand shares were bought and sold for approximately $146.47 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the lower part of a wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $8.33 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 14.59% during the next 3 months and, with a 90% probability hold a price between $9.55 and $11.38 at the end of this 3-month period.

XLO Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, July 23, 2026, and so far it has risen 4.09%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Xilio Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $8.66 and $8.75. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Support, Risk & Stop-loss for Xilio Therapeutics, Inc. stock

Xilio Therapeutics, Inc. finds support from accumulated volume at $8.34 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.330 between high and low, or 3.96%. For the last week the stock has had daily average volatility of 5.90%.

Our recommended stop-loss: $8.28 (-4.31%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 1 day ago.)

Trading Expectations (XLO) For The Upcoming Trading Day Of Monday 27th

For the upcoming trading day on Monday, 27th we expect Xilio Therapeutics, Inc. to open at $8.55, and during the day (based on 14 day Average True Range), to move between $8.45 and $8.85, which gives a possible trading interval of +/-$0.402 (+/-4.76%) up or down from last closing price. If Xilio Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 4.76% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $8.81 (1.85%) than the support at $8.34 (3.58%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Xilio Therapeutics, Inc. stock A Buy?

Xilio Therapeutics, Inc. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

Current score: -0.163 Hold/Accumulate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on July 27, 2026 - $8.55 ( 1.19%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

XLO Performance

Trading levels for XLO

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 8.88 2.62%
R2 8.75 1.16%
R1 8.67 0.263%
Price 8.65
S1 8.42 -2.65%
S2 8.34 -3.55%
S3 8.22 -5.01%

Accumulated Volume Support & Resistance Levels

Level Price
R3 9.31 7.63%
R2 9.03 4.39%
R1 8.81 1.85%
Price 8.65
S1 8.34 -3.58%
S2 8.31 -3.93%
S3 8.25 -4.62%

FAQ

What is the symbol for Xilio Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Xilio Therapeutics, Inc. is XLO and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Xilio Therapeutics, Inc. Stock?
Xilio Therapeutics, Inc. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

How to buy Xilio Therapeutics, Inc. Stock?
Xilio Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Xilio Therapeutics, Inc. Stock.

What's the current price of Xilio Therapeutics, Inc. Stock?
As of the end of day on the Jul 24, 2026, the price of an Xilio Therapeutics, Inc. (XLO) share was $8.65.

What is the 52-week high and low for Xilio Therapeutics, Inc. Stock?
The 52-week high for Xilio Therapeutics, Inc. Stock is $12.74 and the 52-week low is $6.31.

What is the market capitalization of Xilio Therapeutics, Inc. Stock?
As of the Jul 24, 2026, the market capitalization of Xilio Therapeutics, Inc. is 56.875M.

When is the next earnings date for Xilio Therapeutics, Inc.?
The upcoming earnings date for Xilio Therapeutics, Inc. is Aug 13, 2026.
Click to get the best stock tips daily for free!
ABOUT XILIO THERAPEUTICS, INC.
Xilio Therapeutics
Xilio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies to improve the immune system of cancer patients. Its checkpoint inhibitor program includes XTX101, a clinical-stage, tumor-selective anti-CTLA-4 mAb that is in Phase 1/2 clinical trials in patients with solid tumors. The company also develops cytokine programs, which comprises XTX202, a modified form of IL-2; XTX301, an IL-12 product candidate; and XTX401, ...
GOLDEN STAR
Ticker Change Signal Date
KMT
$34.39
2.44% Jul 21
DHT
$17.31
6.59% Jul 13
NMRK
$15.02
2.46% Jun 24
JLL
$299.78
8.56% Jun 24
ROP
$331.60
10.78% Jun 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE